Levita Magnetics surgical robot receives expanded FDA clearance

Levita Magnetics has received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic surgery) system, specifically for use in bariatric and hiatal hernia repair procedures. This expanded indication allows surgeons to treat obesity-related conditions more effectively by enabling simultaneous hiatal hernia repair during bariatric surgery. The system’s Dynamic Magnetic Positioning technology improves surgical access and visibility by retracting the liver in a less invasive manner, reducing the number of incisions needed during abdominal surgeries. Additionally, the FDA cleared Levita’s new 12.5 mm magnetic grasper, designed to enhance control and visualization in patients with high BMI or difficult-to-retract livers by allowing surgeons to grasp the liver more centrally. The MARS system represents a novel approach to robotic surgery by using magnetic forces to internally reposition organs, thereby increasing surgeon control during laparoscopic procedures. It is compact and compatible with existing operating rooms, building on the success of Levita’s earlier Magnetic Surgical System. A notable